Colgate-Palmolive Announces Second Quarter 2026 Results: Key Highlights for Investors
Executive Summary
Colgate-Palmolive Company released its earnings for the quarter ended June 30, 2026, maintaining its sales and GAAP earnings per share (EPS) guidance while updating its gross profit margin and Base Business EPS guidance for the full year. The results and fiscal outlook are of significant relevance to shareholders and may influence Colgate-Palmolive’s share value.
Key Financial Highlights
- Organic Sales Growth: Second quarter organic sales growth was +2.4%, indicating continued momentum in the company’s core business.
- Base Business EPS: Diluted EPS for Base Business reached \$0.99, up 8% from \$0.92 in Q2 2025.
-
GAAP Results:
- Net income attributable to Colgate-Palmolive Company: \$693 million in Q2 2026, compared to \$743 million in Q2 2025.
- Basic earnings per share: \$0.87 in Q2 2026, down from \$0.92 in Q2 2025.
- Operating profit: \$719 million, compared to \$773 million a year ago.
-
Divisional Performance:
- North America Operating Profit: \$192 million for Q2 2026.
- Segment information has been recast to reflect structural changes effective March 31, 2026.
-
Cash Flow and Balance Sheet:
- Free cash flow before dividends: \$1,476 million for the first half of 2026, compared to \$1,252 million in 2025.
- Debt less cash, cash equivalents, and marketable securities: \$7,346 million.
- Working capital as a % of sales: (5.9)%.
-
Dividend and Share Repurchase:
- Dividends paid: \$879 million for the first half of 2026.
- Treasury shares purchased: \$597 million.
- Proceeds from exercise of stock options: \$138 million.
Full Year 2026 Guidance
- Net Sales: Still expected to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.
- Gross Profit Margin: Guidance updated, but the exact figure is not specified in the summary tables.
- Base Business EPS: Guidance updated (details in company’s full release).
Strategic and Structural Updates
- Strategic Growth and Productivity Program: Corporate operating profit for Q2 2026 included charges of \$129 million and \$300 million for the first half, related to this program. These restructuring charges are non-GAAP and excluded from Base Business results.
- Segment Recast: Historical geographic segment information has been recast to conform to the new reporting structure as of Q1 2026.
Management Commentary
“While we expect the volatile market conditions to continue in the balance of 2026, we are confident that the strength of our global portfolio and clear business strategy should enable us to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.”
Non-GAAP Measures
Colgate-Palmolive uses Base Business (non-GAAP) measures to assess performance, excluding restructuring, litigation, acquisition-related costs, and other unusual items. These are used internally for budgeting and compensation, and are believed to enhance investors’ understanding of underlying performance.
Note: Non-GAAP reconciliations are included in the company’s release for the three and six months ended June 30, 2026 and 2025.
Potential Price Sensitive Information
- Maintenance of Sales and EPS Guidance: The company’s decision to maintain its sales and GAAP EPS guidance despite volatile market conditions may reassure investors.
- Gross Profit Margin and EPS Guidance Update: Updating guidance for these metrics could be interpreted by the market as an indicator of improving operational efficiency or changing cost structure.
- Restructuring Charges: Significant charges related to the Strategic Growth and Productivity Program (\$129 million in Q2, \$300 million YTD) may affect reported GAAP earnings but are excluded from Base Business results. Investors should monitor the impact of these charges on future profitability.
- Segment Recast: The change in reporting structure affects how division performance is measured and compared historically, which could impact investor analysis.
- Cash Flow and Shareholder Returns: Strong free cash flow and continued dividend payments, coupled with share repurchases, signal ongoing commitment to shareholder returns.
Risks and Forward-Looking Statements
The company cautions that forward-looking statements are based on management’s current assumptions and plans as of July 31, 2026. These include forecasts about sales, profit, EPS, category growth, FX impacts, geopolitical tensions, and restructuring costs. Actual results may differ materially due to risks such as global trade relations, geopolitical events (including conflicts in Ukraine and the Middle East), cost reduction plans, tax, and legal matters.
Investors should refer to the company’s filings with the SEC (including the “Risk Factors” section of the Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings) for a comprehensive list of potential risks.
Conclusion
Colgate-Palmolive’s Q2 2026 results, guidance updates, and strategic restructuring are important developments for shareholders. The company’s continued growth in organic sales and Base Business EPS, alongside its maintained guidance and strong cash flow, may support share value. However, restructuring charges and ongoing market volatility should be monitored by investors for potential impacts on future performance.
Disclaimer: This article is intended for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult official company filings and financial advisors before making investment decisions. The information presented here is based on the company’s official SEC filings and earnings releases as of July 31, 2026, and may be subject to change.
